Matthew Gline - Director, 10%+ Owner at Arbutus Biopharma Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
ABUS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Gline since 10/15/2024

Holdings reported by Matthew Gline for Arbutus Biopharma Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 38.8M $128M $3.28 Feb 24, 2025 By Roivant Sciences Ltd.

There are no transactions reported by Matthew Gline for Arbutus Biopharma Corp